FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Akums Drugs and Pharmaceuticals IPO and Bansal Wire IPO.
Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Bansal Wire IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Akums Drugs and Pharmaceuticals IPO | Bansal Wire IPO | |
---|---|---|
Logo | ![]() |
![]() |
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited |
SBI Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP ![]() |
DRHP ![]() |
RHP | RHP ![]() |
RHP ![]() |
Anchor Investor | Anchor Investor ![]() |
|
IPO Allotment URL | IPO Allotment URL ![]() |
The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Bansal Wire IPO is up to ₹745.00 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is and of Bansal Wire IPO is ₹256.00 per share.
Akums Drugs and Pharmaceuticals IPO | Bansal Wire IPO | |
---|---|---|
Face Value | ₹2 per share | ₹5 per share |
Issue Price (Lower) | ₹646.00 per share | ₹243.00 per share |
Issue Price (Upper) | ₹679.00 per share | ₹256.00 per share |
Issue Price (Final) | ₹256.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ₹64.00 per share | |
Market Lot Size | 22 shares | 58 shares |
Fresh Issue Size | 1,00,14,727 shares | 2,91,01,562 shares |
Fresh Issue Size (Amount) | up to ₹680.00 Cr | up to ₹745.00 Cr |
OFS Issue Size | 1,73,30,435 shares | |
OFS Issue Size (Amount) | up to ₹1,176.74 Cr | |
Issue Size Total | 2,73,45,162 shares | 2,91,01,562 shares |
Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹745.00 Cr |
Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Bansal Wire IPO opens on Jul 03, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Bansal Wire IPO is Aug 01, 2024, and Jul 05, 2024, respectively.
Akums Drugs and Pharmaceuticals IPO | Bansal Wire IPO | |
---|---|---|
Anchor Bid Date | Jul 29, 2024 | Jul 02, 2024 |
Issue Open | Jul 30, 2024 | Jul 03, 2024 |
Issue Close | Aug 01, 2024 | Jul 05, 2024 |
Basis Of Allotment (Tentative) | Aug 02, 2024 | Jul 08, 2024 |
Initiation of Refunds (Tentative) | Aug 05, 2024 | Jul 09, 2024 |
Credit of Share (Tentative) | Aug 05, 2024 | Jul 09, 2024 |
Listing date (Tentative) | Aug 06, 2024 | Jul 10, 2024 |
Anchor Lockin End date 1 | Sep 01, 2024 | Aug 07, 2024 |
Anchor Lockin End date 2 | Oct 31, 2024 | Oct 06, 2024 |
Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Bansal Wire IPO P/E ratio of 41.41.
Akums Drugs and Pharmaceuticals IPO | Bansal Wire IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Bansal Wire Industries Limited Financial Information (Restated)Bansal Wire Industries Limited's revenue increased by 1.99% and profit after tax (PAT) rose by 31.48% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 84.94% | 73.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 59.92% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 41.41 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹4007.83 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 0.11%% | 21.19%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 3.37%% | 18.46%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.69 | 1.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹6.18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | -0.57% | 18.27%% |
In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered while in Bansal Wire IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Akums Drugs and Pharmaceuticals IPO and 58,20,313 shares in Bansal Wire IPO.
Akums Drugs and Pharmaceuticals IPO | Bansal Wire IPO | |
---|---|---|
Anchor Investor Reserveration | 87,30,468 shares | |
Market Maker Reserveration | ||
QIB | 58,20,313 shares | |
NII | 43,65,234 shares | |
RII | 1,01,85,547 shares | |
Employee | 0 shares | |
Others | ||
Total | 2,03,71,094 shares |
Akums Drugs and Pharmaceuticals IPO subscribed in total, whereas Bansal Wire IPO subscribed 62.76x.
Akums Drugs and Pharmaceuticals IPO | Bansal Wire IPO | |
---|---|---|
QIB (times) | 153.86x | |
NII (times) | 54.21x | |
Big NII (times) | 55.27x | |
Small NII (times) | 52.11x | |
RII (times) | 14.37x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 62.76x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|